ASMA | Annual Summit on Medical Affairs’ Post

The ASMA USA Chapter highlights video here captures the essence of the meeting, including sessions key points and snapshots.

The Pan American Health Organization and its Department of Innovation, Access to Medicines, and Health Technologies (IMT) are pleased to invite you to the webinar “Policies on Access for Managing Medicines and Other Health Technologies Prices: Overview, Experiences, and Challenges in the Americas Region" to be held on Wednesday, November 20, 2024, from 10:00 to 11:30 a.m. (EDT – Eastern Daylight Time, United States). The event will be conducted alternately in three languages: Spanish, English, and Portuguese, with simultaneous interpretation available in any of them. The objective of this webinar is to provide an overview of policies that promote access to medicines and health technologies through price management in the region of the Americas (pricing policies), present a couple of country experiences in price management from different perspectives, and reflect on the progress and challenges in this area. Register here: https://lnkd.in/eWF6jwjh More information and event agenda: https://lnkd.in/eRMVavxY Veronika Wirtz | Warren Kaplan | Daniela Marreco Cerqueira | Hector Hernandez #Health #Prices #Medicines #AccessToMedicines #HealthTechnologies

📢SAVE THE DATE! 📢 🗓️ On 4 September, HNN3.0 organizes a webinar on Pre-Commercial Procurement (PCP) in Horizon Europe and specifically on the Cluster Health topic HORIZON-HLTH-2024-CARE-14-01. ✅ This workshop aims to provide a comprehensive understanding of PCP within the Horizon Europe framework. You will gain insights into both theoretical concepts and practical applications, ensuring you are well-equipped to navigate this complex process. 👥 This workshop is open is to Horizon Europe National Contact Points (NCPs) of Cluster 1 “Health”, as well as Health researchers and innovators (Hospitals, Regions, Health Ministries...), interested in the PCP mechanisms and demand-driven innovation. 👉Find out more and register here: https://lnkd.in/drfahQJd European Commission European Health and Digital Executive Agency (HaDEA) Magnus Wallengren Innovation Skåne Carlos Bezos Daleske Instituto para la Experiencia del Paciente IEXP Lorena Rossi IRCCS INRCA - Istituto Nazionale Ricovero e Cura Anziani Sara Bedin #precommercialprocurement #pcp #procurement #innovation #EUResearch #HealthResearch #health #horizoneurope #cluster1

📢SAVE THE DATE! 📢 🗓️ On 4 September, HNN3.0 organizes a webinar on Pre-Commercial Procurement (PCP) in Horizon Europe and specifically on the Cluster Health topic HORIZON-HLTH-2024-CARE-14-01. ✅ This workshop aims to provide a comprehensive understanding of PCP within the Horizon Europe framework. You will gain insights into both theoretical concepts and practical applications, ensuring you are well-equipped to navigate this complex process. 👥 This workshop is open is to Horizon Europe National Contact Points (NCPs) of Cluster 1 “Health”, as well as Health researchers and innovators (Hospitals, Regions, Health Ministries...), interested in the PCP mechanisms and demand-driven innovation. 👉Find out more and register here: https://lnkd.in/drfahQJd European Commission European Health and Digital Executive Agency (HaDEA) Magnus Wallengren Innovation Skåne Carlos Bezos Daleske Instituto para la Experiencia del Paciente IEXP Lorena Rossi IRCCS INRCA - Istituto Nazionale Ricovero e Cura Anziani Sara Bedin #precommercialprocurement #pcp #procurement #innovation #EUResearch #HealthResearch #health #horizoneurope #cluster1

Watch out! The ASSESS DHT website is now live!   🔍 About ASSESS DHT: ASSESS DHT is a pivotal European initiative to increase the adoption of trustworthy and effective Digital Health Technologies (DHTs). ASSESS-DHT stands at the forefront of evaluating and endorsing #DHTs for their effectiveness, security, and compliance with European health standards. We aim to harmonize the assessment processes, ensuring that DHTs are not only innovative but also trustworthy and beneficial for all users. Our newly launched website serves as a hub for: ✅In-depth information about our project objectives and phases. ✅Insights into our unique approach to developing a harmonized assessment framework for DHTs. ✅Opportunities for collaboration and engagement with stakeholders across various sectors.   🤝 Join Us:  We invite #healthcare professionals, #policymakers, industry experts, academics, and all stakeholders in the digital health ecosystem to explore our website. Your participation and insights are invaluable in shaping a robust and effective framework for DHT assessment, ultimately benefiting patients and healthcare systems across #Europe. Visit our website to learn more: 👉 www.assess-dht.eu   📌 Project consortium: empirica Communication and Technology Research | The European Institute for Innovation Through Health Data | Fundación Progreso y Salud | Technische Universität Dresden | University of Oxford  | NICE - National Institute for Health and Care Excellence | HTA Austria - Austrian Institute for Health Technology Assessment GmbH (AIHTA) | The Dental and Pharmaceutical Benefits Agency, TLV | International Diabetes Federation Europe  | ULB | Technische Universität Berlin | Bettercare | Tech4Care | HeartKinetics    #digitalhealth  #innovation  #ASSESSDHT #DigitalHealth

Counting down the days to the Health Industry Distributors Association (HIDA) Executive Conference! It's a week packed with opportunities to connect and learn from the best in healthcare distribution. I'm looking forward to sharing insights and exploring new trends that can drive our industry forward. If you'll be there, let's make plans to meet up. #HIDAExecutiveConference #HealthcareDistribution

Interested in the open Pre-commercial Procurement Health Call Topic? Then do not miss this webinar!

Interested in exploring new ideas? Join us on Wednesday September 11th at 12:30pm for an insightful Lunch and Learn session hosted by the Health Innovation Fellowship West of England. This session will explore innovation is being leveraged to reduce health inequalities with insights from Huda Hajinur, CEO of Caafi Health and one of our Innovate Healthier Together Fellows. Why sign up? - Connect with fellow professionals who are passionate about innovation in healthcare. - Expand your understanding of the theories and methodologies driving innovative change within BNSSG ICS. - Discover practical insights around innovation that can be applied to your own area of work. - Learn how to harness innovative strategies to enhance service delivery and patient care. - Be a part of the innovation network in BNSSG. Don't miss out on this opportunity to drive innovation in healthcare. Sign up here: https://lnkd.in/er826NXv Let’s continue to change healthcare together! #InnovateHealthierTogether #CaafiHealth #LunchandLearn #HealthInnovation #IHTFellowship #Bristol

The IQVIA UK&I Value and Access Team have developed a 2024/25 PESHTLE analysis of the UK healthcare environment and should be a very helpful summary for Life Science organisations as they go through their strategy planning cycles and should give a good 'steer' on the key elements to include. Watch out this week for more PESHTLE analysis posts from IQVIA! If you would like IQVIA to develop a company-specific PESHTLE analysis to align with your business needs, please send me a message. #marketaccess #lifesciences #pharma #medtech #rarediseases #nhs

Health Technology Assessment is a valuable tool for chronic patients, including those with Inflammatory Bowel Disease (IBD), as it ensures that decisions about healthcare interventions are based on thorough evaluations of their effectiveness, safety, and cost-effectiveness. For IBD patients, HTA provides a structured way to assess not only the clinical benefits of new treatments but also their impact on patients' quality of life, considering factors such as long-term side effects, ease of use, and the potential for personalized medicine. By involving patients directly in the HTA process, their lived experiences and priorities become central to the decision-making process, making healthcare more patient-centered. This is particularly important for chronic diseases like IBD, where treatments need to be effective over the long term and should align with individual patients’ needs. HTA empowers patients by allowing them to influence the development and approval of therapies that are relevant to their daily lives, ultimately leading to better health outcomes and a more efficient use of healthcare resources. In a broader sense, HTA for chronic conditions emphasizes the importance of sustainable healthcare solutions, balancing innovation with accessibility, and ensuring that the best possible care reaches those who need it the most. Join us at the UEG - United European Gastroenterology week with Alessandro Armuzzi, Yago González Lama, Roberto Saldaña, Néboa Zozaya Gonzalez and Fernando Magro European Federation of Crohn's and Ulcerative Colitis Associations #EFCCA #UnitedWeStand #HTA